A detailed history of Tocqueville Asset Management L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 1,377,425 shares of PFE stock, worth $35.3 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
1,377,425
Previous 1,342,299 2.62%
Holding current value
$35.3 Million
Previous $37.6 Million 6.14%
% of portfolio
0.64%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $972,990 - $1.1 Million
35,126 Added 2.62%
1,377,425 $39.9 Million
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $4.36 Million - $5.1 Million
-172,454 Reduced 11.38%
1,342,299 $37.6 Million
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $11.9 Million - $13.7 Million
459,613 Added 43.56%
1,514,753 $42 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $3.56 Million - $4.62 Million
-136,217 Reduced 11.43%
1,055,140 $30.4 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $3.62 Million - $4.23 Million
-112,766 Reduced 8.65%
1,191,357 $39.5 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $1.47 Million - $1.7 Million
40,726 Added 3.22%
1,304,123 $47.8 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $3.04 Million - $3.95 Million
77,091 Added 6.5%
1,263,397 $51.5 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $373,829 - $487,993
-8,954 Reduced 0.75%
1,186,306 $60.8 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $1.22 Million - $1.49 Million
-27,883 Reduced 2.28%
1,195,260 $52.3 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $1.57 Million - $1.86 Million
-33,679 Reduced 2.68%
1,223,143 $64.1 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $1.09 Million - $1.35 Million
-23,861 Reduced 1.86%
1,256,822 $65.1 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $1.12 Million - $1.66 Million
-27,098 Reduced 2.07%
1,280,683 $75.6 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $2.74 Million - $3.52 Million
-69,891 Reduced 5.07%
1,307,781 $56.2 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $6.85 Million - $7.75 Million
-190,620 Reduced 12.15%
1,377,672 $54 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $2.09 Million - $2.36 Million
62,469 Added 4.15%
1,568,292 $56.8 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $3.03 Million - $3.86 Million
-90,670 Reduced 5.68%
1,505,823 $55.4 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $2.81 Million - $3.29 Million
88,357 Added 5.86%
1,596,493 $58.6 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $101,173 - $122,737
-3,359 Reduced 0.22%
1,508,136 $49.3 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $4.7 Million - $6.71 Million
173,812 Added 12.99%
1,511,495 $49.3 Million
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $729,935 - $828,383
22,173 Added 1.69%
1,337,683 $52.4 Million
Q3 2019

Oct 31, 2019

SELL
$32.49 - $42.13 $2.05 Million - $2.65 Million
-62,966 Reduced 4.57%
1,315,510 $47.3 Million
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $725,695 - $814,788
-19,624 Reduced 1.4%
1,378,476 $59.7 Million
Q1 2019

Apr 30, 2019

SELL
$37.5 - $41.2 $1.18 Million - $1.3 Million
-31,498 Reduced 2.2%
1,398,100 $59.4 Million
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $2.5 Million - $2.85 Million
-64,954 Reduced 4.35%
1,429,598 $62.4 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $253,561 - $307,554
7,356 Added 0.49%
1,494,552 $65.9 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $2.99 Million - $3.18 Million
-90,574 Reduced 5.74%
1,487,196 $54 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $6.14 Million - $7.12 Million
-192,277 Reduced 10.86%
1,577,770 $56 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $6.21 Million - $6.59 Million
-186,685 Reduced 9.54%
1,770,047 $64.1 Million
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $60.7 Million - $66.8 Million
1,956,732
1,956,732 $69.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.